Kitty litter dermatitis from 2-bromo-2-nitropropane-1,3-diol

John W. Sullenbarger, Brooke Hensley, Jeffrey Travers

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A 70-year-old white man presented with a 6-week history of an acute pruritic eruption in the axillary vaults, inguinal folds, and central lumbar area. Due to the severity of the pruritus, the patient was evaluated in the emergency department. He was treated with intramuscular triamcinolone, oral fluconazole, clobetasol cream, and miconazole powder, which provided only minimal relief. The patient had presented with brightly erythematous patches in the axillary vaults and inguinal folds with numerous erythematous, scaly, coalescing papules and plaques agminated on the lumbar region (Figure). Due to persistence, despite topical corticosteroids, an allergic contact dermatitis was suspected so patch-testing using the T.R.U.E. Test (SMARTPractice Denmark ApS, Hillerod, Denmark) epicutaneous system was conducted. Results were positive for 5-chloro-2-methyl-4-isothazolinone (panel 2.1, #17), budesonide (panel 3.1, #30), and 2-bromo- 2-nitropropane-1,3-diol, also known as bronopol (panel 3.1, #36). The patient’s topical medications were adjusted based on these results, and he was advised to avoid any products containing these contactants.

Original languageEnglish (US)
Pages (from-to)389-390
Number of pages2
JournalSkinmed
Volume15
Issue number5
StatePublished - Sep 1 2017
Externally publishedYes

Fingerprint

Dermatitis
Groin
Denmark
Clobetasol
Miconazole
Triamcinolone
Lumbosacral Region
Budesonide
Allergic Contact Dermatitis
Fluconazole
Pruritus
Powders
Hospital Emergency Service
Adrenal Cortex Hormones
bronopol

ASJC Scopus subject areas

  • Immunology and Allergy
  • Dermatology

Cite this

Sullenbarger, J. W., Hensley, B., & Travers, J. (2017). Kitty litter dermatitis from 2-bromo-2-nitropropane-1,3-diol. Skinmed, 15(5), 389-390.

Kitty litter dermatitis from 2-bromo-2-nitropropane-1,3-diol. / Sullenbarger, John W.; Hensley, Brooke; Travers, Jeffrey.

In: Skinmed, Vol. 15, No. 5, 01.09.2017, p. 389-390.

Research output: Contribution to journalArticle

Sullenbarger, JW, Hensley, B & Travers, J 2017, 'Kitty litter dermatitis from 2-bromo-2-nitropropane-1,3-diol', Skinmed, vol. 15, no. 5, pp. 389-390.
Sullenbarger JW, Hensley B, Travers J. Kitty litter dermatitis from 2-bromo-2-nitropropane-1,3-diol. Skinmed. 2017 Sep 1;15(5):389-390.
Sullenbarger, John W. ; Hensley, Brooke ; Travers, Jeffrey. / Kitty litter dermatitis from 2-bromo-2-nitropropane-1,3-diol. In: Skinmed. 2017 ; Vol. 15, No. 5. pp. 389-390.
@article{332f46ddaccc4dbdb532eb7452219251,
title = "Kitty litter dermatitis from 2-bromo-2-nitropropane-1,3-diol",
abstract = "A 70-year-old white man presented with a 6-week history of an acute pruritic eruption in the axillary vaults, inguinal folds, and central lumbar area. Due to the severity of the pruritus, the patient was evaluated in the emergency department. He was treated with intramuscular triamcinolone, oral fluconazole, clobetasol cream, and miconazole powder, which provided only minimal relief. The patient had presented with brightly erythematous patches in the axillary vaults and inguinal folds with numerous erythematous, scaly, coalescing papules and plaques agminated on the lumbar region (Figure). Due to persistence, despite topical corticosteroids, an allergic contact dermatitis was suspected so patch-testing using the T.R.U.E. Test (SMARTPractice Denmark ApS, Hillerod, Denmark) epicutaneous system was conducted. Results were positive for 5-chloro-2-methyl-4-isothazolinone (panel 2.1, #17), budesonide (panel 3.1, #30), and 2-bromo- 2-nitropropane-1,3-diol, also known as bronopol (panel 3.1, #36). The patient’s topical medications were adjusted based on these results, and he was advised to avoid any products containing these contactants.",
author = "Sullenbarger, {John W.} and Brooke Hensley and Jeffrey Travers",
year = "2017",
month = "9",
day = "1",
language = "English (US)",
volume = "15",
pages = "389--390",
journal = "Skinmed",
issn = "1540-9740",
publisher = "Le Jacq Communications, Inc.",
number = "5",

}

TY - JOUR

T1 - Kitty litter dermatitis from 2-bromo-2-nitropropane-1,3-diol

AU - Sullenbarger, John W.

AU - Hensley, Brooke

AU - Travers, Jeffrey

PY - 2017/9/1

Y1 - 2017/9/1

N2 - A 70-year-old white man presented with a 6-week history of an acute pruritic eruption in the axillary vaults, inguinal folds, and central lumbar area. Due to the severity of the pruritus, the patient was evaluated in the emergency department. He was treated with intramuscular triamcinolone, oral fluconazole, clobetasol cream, and miconazole powder, which provided only minimal relief. The patient had presented with brightly erythematous patches in the axillary vaults and inguinal folds with numerous erythematous, scaly, coalescing papules and plaques agminated on the lumbar region (Figure). Due to persistence, despite topical corticosteroids, an allergic contact dermatitis was suspected so patch-testing using the T.R.U.E. Test (SMARTPractice Denmark ApS, Hillerod, Denmark) epicutaneous system was conducted. Results were positive for 5-chloro-2-methyl-4-isothazolinone (panel 2.1, #17), budesonide (panel 3.1, #30), and 2-bromo- 2-nitropropane-1,3-diol, also known as bronopol (panel 3.1, #36). The patient’s topical medications were adjusted based on these results, and he was advised to avoid any products containing these contactants.

AB - A 70-year-old white man presented with a 6-week history of an acute pruritic eruption in the axillary vaults, inguinal folds, and central lumbar area. Due to the severity of the pruritus, the patient was evaluated in the emergency department. He was treated with intramuscular triamcinolone, oral fluconazole, clobetasol cream, and miconazole powder, which provided only minimal relief. The patient had presented with brightly erythematous patches in the axillary vaults and inguinal folds with numerous erythematous, scaly, coalescing papules and plaques agminated on the lumbar region (Figure). Due to persistence, despite topical corticosteroids, an allergic contact dermatitis was suspected so patch-testing using the T.R.U.E. Test (SMARTPractice Denmark ApS, Hillerod, Denmark) epicutaneous system was conducted. Results were positive for 5-chloro-2-methyl-4-isothazolinone (panel 2.1, #17), budesonide (panel 3.1, #30), and 2-bromo- 2-nitropropane-1,3-diol, also known as bronopol (panel 3.1, #36). The patient’s topical medications were adjusted based on these results, and he was advised to avoid any products containing these contactants.

UR - http://www.scopus.com/inward/record.url?scp=85047211442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047211442&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 389

EP - 390

JO - Skinmed

JF - Skinmed

SN - 1540-9740

IS - 5

ER -